myeloproliferative love

myeloproliferative

Definitions

from The American Heritage® Dictionary of the English Language, 5th Edition.

  • adjective Relating to or characterized by the proliferation of cells of the bone marrow.

from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • adjective medicine of or pertaining to the presence of an abnormal proliferation of myelopoietic cells (from bone marrow)

Etymologies

Sorry, no etymologies found.

Support

Help support Wordnik (and make this page ad-free) by adopting the word myeloproliferative.

Examples

  • Indeed, as the report said, doctors test for the JAK2 variant to confirm cases of these diseases, called myeloproliferative disorders.

    BusinessWeek.com -- Top News 2012

  • Indeed, as the report said, doctors test for the JAK2 variant to confirm cases of these diseases, called myeloproliferative disorders.

    BusinessWeek.com -- Top News 2012

  • CYT387 is a potent inhibitor of the kinase enzymes JAK1 and JAK2, which have been implicated in a family of hematological conditions known as myeloproliferative neoplasms, including myelofibrosis.

    FinanzNachrichten.de: Aktuelle Nachrichten 2010

  • CYT387 is a potent inhibitor of the kinase enzymes JAK1 and JAK2, which have been implicated in a family of hematological conditions known as myeloproliferative neoplasms, including myelofibrosis.

    BioSpace.com Featured News and Stories 2010

  • CYT387 is an inhibitor of the kinase enzymes JAK1 and JAK2, which have been implicated in a family of hematological conditions known as myeloproliferative neoplasms, including myelofibrosis, and as well in numerous disorders including indications in hematology, oncology and inflammatory diseases.

    Ym Biosciences Reports Significant Response Rates in Anemia, Splenomegaly, and Constitutional Symptoms From the Phase I/II Trial of its Jak1/Jak2 Inhibitor, Cyt387, in Myelofibrosis - Yahoo! Finance 2010

  • CYT387 is a potent inhibitor of the kinase enzymes JAK1 and JAK2, which have been implicated in a family of hematological conditions known as myeloproliferative neoplasms, including myelofibrosis.

    BioSpace.com Featured News and Stories 2010

  • That's what happens in a particular class of blood cell disorders called myeloproliferative neoplasms, or MPNs.

    PhysOrg.com - latest science and technology news stories 2010

  • CYT387 is a potent inhibitor of the kinase enzymes JAK1 and JAK2, which have been implicated in a family of hematological conditions known as myeloproliferative neoplasms, including myelofibrosis.

    THE MEDICAL NEWS Editors 2010

  • The study, published in the journal Nature Genetics, has shown that susceptibility to a series of blood cancers, known as myeloproliferative disorders (MPDs), is linked to a particular area of the patient's DNA, which is prone to developing mutations.

    Health News from Medical News Today 2009

  • The study, published in the journal Nature Genetics, has shown that susceptibility to a series of blood cancers, known as myeloproliferative disorders (MPDs), is linked to a particular area of the patient's DNA, which is prone to developing mutations.

    Medlogs - Recent stories 2009

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.